Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: Final results of the retreatment after herceptin adjuvant trial

1. Láng, I.
2. Bell, R.
3. Feng, F.Y.
4. Lopez, R.I.
5. Jassem, J.
6. Semiglazov, V.
7. Al-Sakaff, N.
8. Heinzmann, D.
9. Chang, J.